These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 911625)

  • 1. The influence of therapeutic doses of spironolactone on the liver microsomal enzyme system and digoxin elimination in man [proceedings].
    Ohnhaus EE; Masson JP
    Br J Clin Pharmacol; 1977 Oct; 4(5):639P-640P. PubMed ID: 911625
    [No Abstract]   [Full Text] [Related]  

  • 2. Different effects of microsomal enzyme inducers on the biliary excretion of digoxin.
    Nevasaari K; Alakare B; Kärki NT
    Acta Pharmacol Toxicol (Copenh); 1976; 39(4):442-8. PubMed ID: 989689
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of spironolactone on excretion of 3H-digoxin and its metabolites in rats.
    Wirth KE; Frölich JC
    Eur J Pharmacol; 1974 Nov; 29(1):43-51. PubMed ID: 4435043
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: The influence of spironolactone on the excretion and metabolism of 3H-digoxin in the rat.
    Wirth KE; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R107. PubMed ID: 4276675
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of phenobarbital, spironolactone and pregnenolone-16 alpha-carbonitrile on rat hepatic beta-glucuronidase.
    Kourounakis PN; Tani E
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):119-22. PubMed ID: 7620833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile secretion and liver microsomal enzyme modifications after chronic treatment with aldosterone, spironolactone, or furosemide.
    Afifi F
    Indian J Exp Biol; 1983 Dec; 21(12):686-9. PubMed ID: 6678224
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of spironolactone on bile formation and liver microsomal enzymic activities in the rat (author's transl)].
    Miguet JP; Mavier P; Arondel J; Preaux AM; Dhumeaux D
    Gastroenterol Clin Biol; 1977; 1(12):1007-13. PubMed ID: 606621
    [No Abstract]   [Full Text] [Related]  

  • 8. Modifications of bile secretion and liver microsomal enzymes by aldosterone and spironolactone.
    Afifi F; Peignoux M; Auclair C
    Hepatogastroenterology; 1980 Feb; 27(1):9-16. PubMed ID: 7203360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal enzyme induction in patients with decompensated cirrhosis.
    Cooksley WG; Powell LW
    Gastroenterology; 1980 Oct; 79(4):778-80. PubMed ID: 7409401
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteration of digoxin toxicity by 6-hydroxydopamine and soironolactone.
    Anders JC; Crisona FJ; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):459-72. PubMed ID: 7423022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of spironolactone on drug metabolism by hepatic microsomes.
    Stripp B; Hamrick ME; Zampaglione NG; Gillette JR
    J Pharmacol Exp Ther; 1971 Mar; 176(3):766-71. PubMed ID: 5111461
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of uridine diphosphoglucuronic acid on bilirubin glucuronidation in liver microsomes from normal and spironolactone-treated rats.
    Mottino AD; Rodríguez Garay EA
    Acta Physiol Pharmacol Latinoam; 1987; 37(4):479-84. PubMed ID: 3152590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spironolactone on the renal clearance of digoxin in dogs.
    O'Brien MS; Salamone LF; Gibson TP
    J Pharmacol Exp Ther; 1985 Jul; 234(1):190-4. PubMed ID: 4009501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of diphenylhydantoin and spironolactone on the digoxin pharmacokinetics in the rabbit (author's transl)].
    Tato F; Pérez Fontán J; Lloveres J
    Arch Farmacol Toxicol; 1980 Aug; 6(2):151-60. PubMed ID: 7469497
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides.
    Klaassen CD
    J Pharmacol Exp Ther; 1974 Nov; 191(2):201-11. PubMed ID: 4418514
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions between digoxin and potassium-sparing diuretics.
    Waldorff S; Hansen PB; Egeblad H; Berning J; Buch J; Kjaergård H; Steiness E
    Clin Pharmacol Ther; 1983 Apr; 33(4):418-23. PubMed ID: 6831820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin.
    Ghanem CI; Gómez PC; Arana MC; Perassolo M; Delli Carpini G; Luquita MG; Veggi LM; Catania VA; Bengochea LA; Mottino AD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1146-52. PubMed ID: 16740618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
    Chung WG; Buhler DR
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3-digitoxin and its metabolites following spironolactone pretreatment of rats.
    Castle MC; Lage GL
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):601-12. PubMed ID: 4750104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.